TREA

90796010 - EPICENTRX

Follow

Information

  • Trademark
  • 90796010
  • Serial Number
    90796010
  • Filing Date
    June 25, 2021
    5 years ago
  • Transaction Date
    July 03, 2025
    a year ago
  • Status Date
    January 04, 2025
    a year ago
  • Published for Opposition Date
    November 08, 2022
    3 years ago
  • Location Date
    January 03, 2023
    3 years ago
  • Status Code
    733
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    LOVELACE, JAMES
  • Attorney Docket Number
    203596001000
    Attorney Name
    Muzamil Huq
    Law Office Assigned Location Code
    N10
  • Owners
Information
Mark Drawing Code
4
Mark Identification
EPICENTRX
Case File Statements
  • GS0051: Pharmaceutical products, preparations, and substances for the prevention and treatment of cancer, infectious diseases, allergies, mental illnesses, chemotherapy side effects, radiation side effects, transplantation side effects, and viral, metabolic, cardiovascular, vascular, pulmonary, blood, dermatologic, fibrotic, autoimmune, inflammatory, neurodegenerative, neuromuscular, dietary deficiency, hereditary, endocrine, eye, ear, and voice related diseases and disorders; biological products, preparations, and substances being medical preparations for the prevention and treatment of cancer, infectious diseases, allergies, mental illnesses, chemotherapy side effects, radiation side effects, transplantation side effects, and viral, metabolic, cardiovascular, vascular, pulmonary, blood, dermatologic, fibrotic, autoimmune, inflammatory, neurodegenerative, neuromuscular, dietary deficiency, hereditary, endocrine, eye, ear, and voice related diseases and disorders; immunotherapies in the nature of medical preparations for the prevention and treatment of cancer, infectious diseases, allergies, mental illnesses, chemotherapy side effects, radiation side effects, transplantation side effects, and viral, metabolic, cardiovascular, vascular, pulmonary, blood, dermatologic, fibrotic, autoimmune, inflammatory, neurodegenerative, neuromuscular, dietary deficiency, hereditary, endocrine, eye, ear, and voice related diseases and disorders; vaccines; pharmaceuticals in the nature of biotechnology platform technology, namely, viral and vaccine vectors for delivery and insertion of function-altering genetic material into human and animal patients, plants, and crops, for visualization of specific cell types, for inducing humoral and cell-mediated responses, for targeting and killing cancer cells, for removing pathological functions, for controlling biological pests, and for boosting crop yields; chemical platform technology, namely, small molecule compounds being pharmaceuticals for inducing the expression of antioxidant, anti-inflammatory, and cytoprotective proteins in non-malignant tissues, for activating the immune system, for modulating blood flow in ischemic tissues, for upregulating proinflammatory mediators in tumors, and for treating plant diseases
  • PM0001: EPICENT RX
  • GS0421: Scientific and medical research and development in the fields of pharmaceuticals, biologics, agriculture, pest control, biotechnology, immunotherapies, and vaccines
Case File Event Statements
  • 6/29/2021 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 9/9/2021 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/22/2022 - 4 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/22/2022 - 4 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/16/2022 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/22/2022 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/22/2022 - 4 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/23/2022 - 4 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/22/2022 - 4 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/3/2022 - 3 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/8/2022 - 3 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/19/2022 - 3 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/8/2022 - 3 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/3/2023 - 3 years ago
    14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 7/3/2023 - 3 years ago
    16 - SOU EXTENSION 1 FILED Type: EXT1
  • 7/3/2023 - 3 years ago
    17 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 7/5/2023 - 3 years ago
    18 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/22/2023 - 2 years ago
    19 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 7/3/2023 - 3 years ago
    15 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/22/2023 - 2 years ago
    20 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 12/22/2023 - 2 years ago
    21 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/3/2024 - 2 years ago
    22 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/3/2024 - 2 years ago
    23 - SOU EXTENSION 2 FILED Type: EXT2
  • 1/3/2024 - 2 years ago
    24 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 1/5/2024 - 2 years ago
    25 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/2/2024 - 2 years ago
    26 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/2/2024 - 2 years ago
    29 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/2/2024 - 2 years ago
    27 - SOU EXTENSION 3 FILED Type: EXT3
  • 7/2/2024 - 2 years ago
    28 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 1/3/2025 - a year ago
    30 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/4/2025 - a year ago
    31 - SOU EXTENSION 4 FILED Type: EXT4
  • 1/4/2025 - a year ago
    32 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 3/4/2025 - a year ago
    33 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/1/2025 - a year ago
    34 - SOU TEAS EXTENSION RECEIVED Type: EEXT